Literature DB >> 33577874

Impact of Antimicrobial Resistance Rates on Eradication of Helicobacter pylori in a US Population.

Erick A Argueta1, Mohd Amer Alsamman2, Steven F Moss3, Erika M C D'Agata4.   

Abstract

Entities:  

Keywords:  23S rRNA; Amoxicillin; Clarithromycin; Levofloxacin; Metronidazole; Next Generation Sequencing; Rifabutin; Tetracycline

Mesh:

Substances:

Year:  2021        PMID: 33577874      PMCID: PMC9115583          DOI: 10.1053/j.gastro.2021.02.014

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

1.  Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication: A Double-Blind, Randomized, Controlled Trial.

Authors:  David Y Graham; Yamil Canaan; James Maher; Gregory Wiener; Kristina G Hulten; Ira N Kalfus
Journal:  Ann Intern Med       Date:  2020-05-05       Impact factor: 25.391

2.  ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Authors:  William D Chey; Grigorios I Leontiadis; Colin W Howden; Steven F Moss
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

3.  Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA.

Authors:  Jason Y Park; Kerry B Dunbar; Midori Mitui; Christina A Arnold; Dora M Lam-Himlin; Mark A Valasek; Irene Thung; Chinemerem Okwara; Elizabeth Coss; Byron Cryer; Christopher D Doern
Journal:  Dig Dis Sci       Date:  2016-02-29       Impact factor: 3.199

4.  Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans.

Authors:  Seiji Shiota; Rita Reddy; Abeer Alsarraj; Hashem B El-Serag; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2015-02-11       Impact factor: 11.382

Review 5.  Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions.

Authors:  Alessia Savoldi; Elena Carrara; David Y Graham; Michela Conti; Evelina Tacconelli
Journal:  Gastroenterology       Date:  2018-07-07       Impact factor: 22.682

  5 in total
  7 in total

Review 1.  Management of Helicobacter pylori Infection: A Comparison between Korea and the United States.

Authors:  Sung Eun Kim; Joo Ha Hwang
Journal:  Gut Liver       Date:  2021-10-25       Impact factor: 4.321

Review 2.  Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Clin Microbiol Rev       Date:  2022-04-11       Impact factor: 50.129

3.  Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years.

Authors:  Xiaoli Shu; Diya Ye; Chenmin Hu; Kerong Peng; Hong Zhao; Huamei Li; Mizu Jiang
Journal:  Sci Rep       Date:  2022-10-22       Impact factor: 4.996

Review 4.  Primer for Development of Guidelines for Helicobacter pylori Therapy Using Antimicrobial Stewardship.

Authors:  David Y Graham; Jyh-Ming Liou
Journal:  Clin Gastroenterol Hepatol       Date:  2021-03-26       Impact factor: 13.576

5.  The Influence of Past Metronidazole Exposure on the Outcome of Helicobacter pylori Eradication.

Authors:  Younghee Choe; Joon Sung Kim; Hyun Ho Choi; Dae Bum Kim; Jae Myung Park; Jung Hwan Oh; Tae Ho Kim; Dae Young Cheung; Woo Chul Chung; Byung-Wook Kim; Sung Soo Kim
Journal:  Front Microbiol       Date:  2022-03-25       Impact factor: 5.640

Review 6.  Pitfalls of Physician-Directed Treatment of Helicobacter pylori: Results from Two Phase 3 Clinical Trials and Real-World Prescribing Data.

Authors:  Colin W Howden; Kely L Sheldon; June S Almenoff; William D Chey
Journal:  Dig Dis Sci       Date:  2021-12-04       Impact factor: 3.487

7.  Comparison of Culture With Antibiogram to Next-Generation Sequencing Using Bacterial Isolates and Formalin-Fixed, Paraffin-Embedded Gastric Biopsies.

Authors:  Kristina G Hulten; Robert M Genta; Ira N Kalfus; Yi Zhou; Hongjun Zhang; David Y Graham
Journal:  Gastroenterology       Date:  2021-07-19       Impact factor: 33.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.